Ma Iune 16-17, 2023, ua komo ʻo MedGence i ka Conference on High-Quality Development of Healthcare Industry & the 8th Summit for China Pharmaceutical R&D Innovation, i mālama maikaʻi ʻia ma Chongqing.
Ua hoʻohanohano ʻia ʻo MedGence ma ke ʻano he "2023 Top 20 R&D CRO Enterprises ma Kina"!
ʻO ka mea mua, ma ka wehe ʻana, ua hoʻokuʻu ʻia ka papa inoa "2022 China Pharmaceutical R&D Strength Ranking" a ua hoʻohanohano ʻia ʻo MedGence ma ke ʻano he "2023 Top 20 Pharmaceutical CRO Enterprises ma Kina"!
Ua koho ʻia ka "2023 Pharmaceutical CRO Enterprises in China" e ka CRO Ranking Expert Review Committee ma muli o 10 mau hōʻailona a me nā ʻāpana he nui, e like me ka huina kālā makahiki (loaʻa kālā), ka ulu kālā makahiki (%), ka loaʻa kālā, ka ulu ʻana o ka waiwai (%), ka hoʻopukapuka R&D, ka ulu ʻana o ka waiwai R&D (%), ka nui o nā limahana, ka ulu nui o nā limahana (%), ka ʻike hou ʻana i ka lāʻau lapaʻau, a me ke alakaʻi ʻana i ka lāʻau lapaʻau hou. ʻO ka hui hoʻomohala, lanakila i ka makana "2023 Top 20 Pharmaceutical CRO Enterprises ma Kina", hōʻike i kona hiki a me kona ikaika.
I kēia manawa, ma ke ʻano he alakaʻi o TCM CXO, ua kono ʻia ʻo Dr. Yi Yueneng, ka Luna Hoʻomalu a me ka luna nui o MedGence e hele i ka ʻEwalu Summit no China Pharmaceutical R&D Innovation a hāʻawi i kahi haʻiʻōlelo ma "E hoʻomaka ana mai ka hopena - Strategies for the Development of New Chinese Medicine". Ua kuhikuhi ʻo ia i kēia manawa, ua wikiwiki a hoʻomaikaʻi ʻia ka hoʻolālā kiʻekiʻe o ka hoʻomohala ʻana i nā lāʻau lapaʻau Kina, ua hoʻomau mau ʻia ke ʻano kulekele a ua hoʻonui ʻia ke kākoʻo, a ua hoʻomaka ka lāʻau lapaʻau Kina i kahi makahiki gula. Ua hoʻokaʻawale ʻo ia i ke kaiapuni kulekele, ke kaʻina hana noiʻi a me ka hoʻomohala ʻana, a me ke kūlana noiʻi o ka hoʻomohala ʻana i ka ʻoihana lapaʻau Kina maʻamau i ke au hou, hōʻike i ka pilina kūloko kūloko, kālailai i nā pilikia koʻikoʻi e mau nei i ka hoʻomohala ʻana o ka ʻoihana lapaʻau Kina kuʻuna, a me ka hoʻoholo ʻana i nā mea kūpono.
A laila, ʻo Dr. Yi Yueneng, ʻo ia ka mea hoʻokipa o ka ʻaha papa ʻaina ma ka "Is the Spring of Chinese Medicine New Product R&D Coming", i kūkākūkā pū i nā ʻano a me nā pilikia o ka R&D a me ka hana hou o ka lāʻau lapaʻau Kina me nā mea pāʻani ʻoihana. Ma ke ʻano he hui hui nui, ua paʻa mau ʻo MedGence i ka ʻoihana lāʻau lapaʻau, e ʻimi ikaika ana, e hoʻomau mau ana, e hāpai ana i ka hoʻomohala ʻana i ka ʻoihana, a me ka hoʻomau ʻana i ka lawelawe ʻana i nā hui lāʻau lapaʻau a puni Kina.
Ua hoʻokipa ka hui i nā alakaʻi he nui i ke ʻano o ka hoʻoponopono lāʻau lapaʻau, nā koleke a me nā kulanui, nā keʻena noiʻi, nā hui lāʻau lapaʻau, nā ʻāpana R&D a me nā mea elite ʻē aʻe e komo i nā hōʻike kumuhana e pili ana i ka R&D o nā lāʻau lapaʻau Kina, ka hoʻomākaukau ʻana i nā mea hou, nā lula a me nā kulekele, ka maikaʻi a me ka palekana, ka hoʻoponopono ʻana, nā mea hana hou a me nā ʻenehana hou. ʻO nā lāʻau lapaʻau, ʻo ia kekahi o nā mea hōʻikeʻike kūikawā o ka hanana, he hale kūʻai kūikawā, kahi i huki ai i ka nui o nā hoa hana ma ka ʻoihana e kipa! I ka wā o ka piko, ʻo ia kekahi o nā mea hōʻike i kono ʻia, ua loaʻa iā Enable Pharma kahi hale kūʻai kūikawā, kahi i huki ai i nā hoahana ʻoihana he nui e kipa aku i ka hale hoʻokipa no ke kūkākūkā ʻana, ke kamaʻilio kokoke ʻana me nā hui lāʻau lapaʻau nui, a me ka noi docking no ka noiʻi lāʻau a me ka hoʻomohala ʻana.
Ka manawa hoʻouna: Iulai-15-2023